» Articles » PMID: 6441781

The Effects of CaEDTA Injection on Lead, Zinc, Copper and ALAD in Erythrocyte, Plasma and Urine in Lead-exposed Workers: a 24-h Observation

Overview
Date 1984 Jan 1
PMID 6441781
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the effects of calcium disodium ethylenediamine tetraacetate (CaEDTA) on the concentrations of lead, zinc and copper in plasma, erythrocyte and urine, and the delta-aminolevulinic acid dehydratase (ALAD) activity in erythrocyte, we administered CaEDTA in 1-h intravenous infusion to ten male gun metal founders with blood-lead concentration of 39 to 64 micrograms/dl (mean 49 micrograms/dl). We found that the plasma concentration of lead, following a rapid rise within the first 3 h, fell temporarily to the level significantly lower than the initial level 19 h after start of the infusion. The plasma concentration of zinc fell to the minimal level 5 h after the infusion; and the erythrocyte concentration of zinc and the ALAD activity concurrently rose to the maximal level 5 h after the infusion. By contrast, no significant alteration was observed in the concentrations of copper in plasma and erythrocyte. The maximal level of urinary metal excretion was attained during the period between 1 and 2 h after start of CaEDTA infusion for lead; within 2 h for zinc; and between 2 and 4 h for copper. The urinary metal excretion returned to the initial level 14 to 24 h after infusion for zinc and copper; but lead excretion was still higher than the initial level during this period. The difference in the kinetics of the three metals following CaEDTA injection is discussed in the light of these findings.

Citing Articles

Neuronal Zinc Transporter ZnT3 Modulates Cerebral Ischemia-Induced Blood-Brain Barrier Disruption.

Qi Z, Zhou X, Dong W, Timmins G, Pan R, Shi W Aging Dis. 2023; 15(6):2727-2741.

PMID: 37962463 PMC: 11567248. DOI: 10.14336/AD.2023.1011.


Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms.

Hu H, Rabinowitz M, Smith D Environ Health Perspect. 1998; 106(1):1-8.

PMID: 9417769 PMC: 1532948. DOI: 10.1289/ehp.981061.


Effects of lead, zinc and copper absorption on peripheral nerve conduction in metal workers.

Murata K, Araki S, Aono H Int Arch Occup Environ Health. 1987; 59(1):11-20.

PMID: 3793240 DOI: 10.1007/BF00377674.


Determination of the distribution of conduction velocities in workers exposed to lead, zinc, and copper.

Araki S, Yokoyama K, Murata K, Aono H Br J Ind Med. 1986; 43(5):321-6.

PMID: 3707869 PMC: 1007655. DOI: 10.1136/oem.43.5.321.


Central and peripheral nervous system dysfunction in workers exposed to lead, zinc and copper. A follow-up study of visual and somatosensory evoked potentials.

Araki S, Murata K, Aono H Int Arch Occup Environ Health. 1987; 59(2):177-87.

PMID: 3557626 DOI: 10.1007/BF00378495.


References
1.
Berlin A, Schaller K . European standardized method for the determination of delta-aminolevulinic acid dehydratase activity in blood. Z Klin Chem Klin Biochem. 1974; 12(8):389-90. View

2.
MEREDITH P, Moore M . The in vivo effects of zinc on erythrocyte delta-aminolaevulinic acid dehydratase in man. Int Arch Occup Environ Health. 1980; 45(2):163-8. DOI: 10.1007/BF01274135. View

3.
Thomasino J, Zuroweste E, Brooks S, Petering H, Lerner S, FINELLI V . Lead, zinc, and erythrocyte delta-aminolevulinic acid dehydratase: relationships in lead toxicity. Arch Environ Health. 1977; 32(6):244-7. DOI: 10.1080/00039896.1977.10667290. View

4.
Araki S, Aono H, Fukahori M, Tabuki K . Behavior of lead and zinc in plasma, erythrocytes, and urine and ALAD in erythrocytes following intravenous infusion of CaEDTA in lead workers. Arch Environ Health. 1984; 39(5):363-7. DOI: 10.1080/00039896.1984.10545865. View

5.
DeSilva P . Determination of lead in plasma and studies on its relationship to lead in erythrocytes. Br J Ind Med. 1981; 38(3):209-17. PMC: 1008877. DOI: 10.1136/oem.38.3.209. View